Does ENZALUTAMIDE Cause Gynaecomastia? 175 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Gynaecomastia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.4% of all adverse event reports for ENZALUTAMIDE.
175
Reports of Gynaecomastia with ENZALUTAMIDE
0.4%
of all ENZALUTAMIDE reports
5
Deaths
13
Hospitalizations
How Dangerous Is Gynaecomastia From ENZALUTAMIDE?
Of the 175 reports, 5 (2.9%) resulted in death, 13 (7.4%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Gynaecomastia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 175 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Gynaecomastia?
RISPERIDONE (24,453)
PALIPERIDONE (4,155)
QUETIAPINE (535)
FINASTERIDE (428)
ARIPIPRAZOLE (393)
OLANZAPINE (389)
LEUPROLIDE (363)
SPIRONOLACTONE (307)
DIVALPROEX (226)
METHYLPHENIDATE (201)
Which ENZALUTAMIDE Alternatives Have Lower Gynaecomastia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE